Ayala Healthcare acquires Healthway chain of clinics

Font Size

AYALA Healthcare Holdings, Inc. (AC Health) said it acquired 100% of clinic network Healthway from Hong Kong’s HKR International Ltd (HKRI).

“We are very pleased to welcome Healthway to AC Health and the Ayala group. The Healthway name has become synonymous with quality healthcare and has been well-regarded among patients and medical professionals. We intend to build on this further, as we integrate Healthway with our AC Health portfolio,” AC Health Chairman Fernando Zobel de Ayala said in a statement Friday.

The agreement was signed Friday by Healthway Philippines President and Chief Executive Officer Sidney Hui, Mr. Zobel de Ayala, and AC Health President and Chief Executive Officer Paolo Maximo F. Borromeo.

The acquisition augments the AC Health network with Healthway’s seven mall-based multi-specialty clinics, and 40 corporate clinics. AC Health currently has 70 community-based care clinics under the FamilyDOC brand, and 10 corporate clinics.

“Healthway is an excellent fit and is extremely complementary to our portfolio. Apart from growing our clinic count and patient base, this acquisition also allows us to serve different types of patients across multiple clinic formats,” Mr. Borromeo said.

“Whether it be in primary care, multi-specialty care, or corporate clinics. We see many opportunities for synergy, including patient referrals, sharing of medical professionals, and integration of diagnostics and pharmacy services,” he added.

AC Health recenly acquired a minority stake in IE Medica, a major pharmaceutical importer, as well as MedEthix, its affiliated distribution firm.

Mr. Borromeo said that the company is also finalizing a joint venture with an international cancer center operator for a specialty cancer hospital. It is scheduled to open in 2022.

“This is an exciting time for us at AC Health. Taken together, all of these investments bring us closer to realizing our vision of an integrated healthcare ecosystem. We are still looking to grow our portfolio further, particularly in retail pharma, financing, and hospitals. Ultimately, our goal is to touch the lives of 1 in 5 Filipinos by 2030,” Mr. Borromeo said.

The Ayala group is targeting to expand its health care business to more than 1,000 Generika pharmacies, 100 FamilyDOC clinics, and more strategic partnerships with hospitals and specialty centers.